Fred Hutch researchers have created a gene-expression map of glial cells of the tiny worm, C. elegans, adding the missing ...

A new AI application that is part of an 'ambient listening' pilot program is helping physicians at Fred Hutch Cancer Center ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

Tammy Miller has been a wealth and philanthropy advisor for over 30 years. As executive director of the Aldarra Foundation, ...

The Oral Medicine Services team at Fred Hutch Cancer Center addresses the complex oral health needs of patients undergoing ...

Diagnosed with a rare childhood cancer discovered just in time, surgery, proton therapy and chemotherapy saved two-year-old ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

SEATTLE — June 17, 2025 — Fred Hutch Cancer Center announced eight recipients of the 2025 Dr. Eddie Méndez Scholar Award. The award honors outstanding achievements of early-career scientists studying ...

Fred Hutch board members Ric Anderson and Eduardo Peñalver take on new leadership roles, Jim Lico joins Board of Directors ...

Faculty profile for Dr. Christopher D. Blosser. Dr. Blosser is a transplant nephrologist and medical director of the Cancer ...

Immunocompromised: more vulnerable, less studied As of 2021, the National Health Interview Survey calculated that 7% of the U.S. population (more than 23 million people), were immunosuppressed.

Fred Hutch Cancer Center aims to enroll 200,000 patients over the next 10 years in a new research program called TakePART-NW (Patients and Research Together-Northwest) to improve screening, prevention ...